Pfizer

The products, which are widely available in the US and the European Union, include 23 medicines and vaccines that treat infectious diseases, some cancers and rare and inflammatory conditions

Pfizer has announced it is to supply all its current and future patent-protected medicines and vaccines on a not-for-profit basis to 45 lower-income countries and is talking to other big drugmakers

World Economic Forum (WEF) 2022: The initiative by Pfizer was launched at the World Economic Forum Annual Meeting in Davos 2022

Pfizer said that preliminary clinical data showed their three-dose Covid-19 vaccine regimen was 80 per cent effective for children aged between 6 months to 5-years-old

Three doses of Pfizer's COVID-19 vaccine offer strong protection for children younger than 5, the company announced Monday.

The US FDA has granted emergency use authorisation for a booster dose of the Pfizer-BioNTech vaccine for children aged between 5-11 years at least 5 months after completion of primary vaccine series

The Covid-19 portfolio contributed 5-6 per cent of Cipla's turnover during peak Covid waves, the firm said

Pfizer will pay $148.50 a share for all of New Haven, Connecticut-based Biohaven's outstanding stock, according to a statement Tuesday

The centre integrates two essential functions under the export-oriented undertaking of Pfizer: Pharmaceutical Sciences (PharmSci) and Global Technology and Engineering (GT&E) Centre of Excellence.

Sales of Pfizer's COVID-19 vaccine and treatment pushed the drugmaker well past expectations in the first quarter, as profit grew 61per cent.

The trial failure, along with reports of rebounding coronavirus levels in some patients who have completed a course of Paxlovid, are unlikely to change the drug's sales potential

'Hire me to run Twitter as VP of Product,' tweeted Nikita Bier, co-founder of a positivity-focused polling app called tbh that was acquired by Meta Platforms

This assumes significance as Covid cases are on the rise in the country, especially in the National Capital Region (NCR)

Now Pfizer says new data shows healthy 5- to 11-year-olds could benefit from another kid-sized shot

Covid vaccines

A 4th dose of Pfizer vaccine lowered rates of Covid-19 among people aged 60 years or older but protection against the infection appeared short-lived, according to a study conducted in Israel

GlaxoSmithKline's IV drug for Covid-19 should no longer be used because it is likely ineffective against the omicron subvariant that now accounts for most US cases, federal health regulators said

FDA authorises another booster dose of the Pfizer or Moderna Covid vaccine for people age 50 and up

Branded as Kovidax, Strides' generic version of the Pfizer oral treatment will be launched in 95 markets as part of the sub-licensing agreement with Medicines Patent Pool (MPP), the drug firm said

Among individual stocks, Aurobindo Pharma was the top gainer, which rallied 8 per cent to Rs 688.90 on the BSE in intra-day trade.